Arjo, officially known as Arjo AB, is a leading global provider of medical technology solutions headquartered in Sweden (SE). Founded in 1957, the company has established a strong presence in Europe, North America, and Asia, focusing on enhancing the quality of care for patients and healthcare professionals alike. Specialising in areas such as patient handling, wound care, and infection prevention, Arjo offers a range of innovative products and services designed to improve patient mobility and safety. Their unique approach combines advanced technology with ergonomic design, setting them apart in the healthcare industry. With a commitment to sustainability and patient-centric solutions, Arjo has achieved significant milestones, including numerous awards for innovation and excellence in healthcare. As a trusted partner in the medical sector, Arjo continues to strengthen its market position through ongoing research and development.
How does Arjo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Arjo's score of 46 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Arjo AB reported total carbon emissions of approximately 8,509,710 kg CO2e, comprising 5,377,960 kg CO2e from Scope 1, 754,300 kg CO2e from Scope 2, and 2,377,450 kg CO2e from Scope 3 emissions. This marks a significant commitment to reducing greenhouse gas emissions, with a target to cut Scope 1 and 2 emissions by 50% by 2030, using 2021 as the baseline year. Additionally, Arjo aims to reduce Scope 3 emissions from purchased goods and services, upstream transportation and distribution, and the use of sold products by 25% within the same timeframe. In 2023, the company’s global emissions were reported at approximately 237,264,000 kg CO2e, with Scope 1 emissions at 21,388,000 kg CO2e, Scope 2 at 2,750,000 kg CO2e, and Scope 3 at 213,126,000 kg CO2e. This data reflects a comprehensive approach to emissions management, with all scopes disclosed. Arjo's climate commitments are aligned with the Science Based Targets initiative (SBTi), ensuring that their reduction targets are consistent with the necessary reductions to limit global warming to 1.5°C. The company is actively working towards these goals, demonstrating a robust strategy for sustainability in the healthcare equipment sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 22,362,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 2 | 3,380 | 0,000 | 0,000,000 | 0,000,000 | 0,000,000 | 
| Scope 3 | 61,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 
Arjo's Scope 3 emissions, which decreased by 15% last year and increased by approximately 249% since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 67% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Arjo has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
